| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |